CL 403 Pill - yellow capsule/oblong, 19mm
Pill with imprint CL 403 is Yellow, Capsule/Oblong and has been identified as Nevirapine Extended-Release 400 mg. It is supplied by Cipla USA Inc.
Nevirapine is used in the treatment of HIV Infection; Reduction of Perinatal Transmission of HIV and belongs to the drug class NNRTIs. There is no proven risk in humans during pregnancy. Nevirapine 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CL 403
Nevirapine Extended-Release
- Imprint
- CL 403
- Strength
- 400 mg
- Color
- Yellow
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- NNRTIs
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla USA Inc.
- National Drug Code (NDC)
- 69097-0403 (Discontinued)
- Inactive Ingredients
-
lactose monohydrate,
hypromelloses,
ferric oxide yellow,
magnesium stearate
Note: Inactive ingredients may vary.
Related images for "CL 403"
More about nevirapine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (6)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: NNRTIs
- Breastfeeding
- En español
Patient resources
- Nevirapine drug information
- Nevirapine (Advanced Reading)
- Nevirapine Tablets
- Nevirapine Oral Suspension
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
